Baseline demographic and clinical characteristics of the included population

Reference Total CG TG Mean age (yr)a Sex (M/F)a ASA (I/II/III)a BMI (kg/m2)a
Adams et al. [24] 42 21 21 69 vs.70 7/14 vs. 5/16 NR NR
Barrington et al. [32] 108 55 53 71 ± 9 vs. 69 ± 10 25/30 vs. 26/27 NR 31 ± 5.2 vs. 33 ± 6.1
Campbell et al. [25] 60 31 29 70 ± 8.4 vs. 72 ± 9.9 14/17 vs. 14/15 2.2 ± 0.6 vs. 2.2 ± 0.6 30.8 ± 4.8 vs. 29.1 ± 4.6
Capdevila et al. [26] 37 17 20 51 ± 15 vs. 54 ± 17 10/7 vs. 8/12 ASA I or II NR
Davies et al. [33] 60 30 30 73.1 ± 9.0 vs. 72.3 ± 9.5 13/17 vs. 19/11 NR NR
Sakai et al. [13] 60 30 30 73 (53-86) vs. 72 (48-84) 4/26 vs. 4/26 1/26/3 vs. 2/24/4 24.8 (16.4-33.3) vs. 24.8 (19.1-37.0)
Shanthanna et al. [30] 38 19 19 63.6 ± 5.0 vs. 63.5 ± 5.0 11/8 vs. 10/9 NR NR
Singelyn et al. [2] 30 15 15 NR NR ASA II or III NR
Zaric et al. [31] 49 23 26 67 ± 6 vs. 66 ± 7 12/11 vs. 11/15 3/20/0 vs. 4/17/5/0 NR
Chelly et al. [35] 59 30 29 70 (65-74) vs. 66 (60-74) NR NR NR
Horasanli et al. [28] 76 39 37 54.0 ± 16.9 vs. 51.3 ± 14.9 27/12 vs. 24/13 14/29/0 vs. 14/23/0 NR
Kim et al. [29] 80 40 40 67.4 ± 1.3 vs. 71.8 ± 1.3 4/36 vs. 3/37 1/38/0 vs. 2/36/2 NR
Raimer et al. [34] 42 21 21 64 (61-73) vs. 69 (61-75) 7/14 vs. 10/11 2/12/7 vs. 2/15/4 33 (28-35) vs. 30 (26-34)
Al-Zahrani et al. [36] 50 25 25 60 ± 8.5 vs. 62 ± 7.5 7/18 vs. 8/17 2/23/0 vs. 6/19/0 33 ± 5 vs. 33 ± 5
Fedriani de Matos et al. [27] 58 30 28 68.6 ± 6.5 vs. 68.0 ± 8.2 70%/30% 32%/68% 0%/80%/20% vs. 4%/89%/7% 33.5 ± 8.5 vs. 30.8 ± 5.0
Kayupov et al. [37] 132 44 41/47 64/63/60 45%/55% 46%/54% 59%/41% NR 30/31/31

CG: control group, TG: test group, ASA: American Society of Anesthesiologists , BMI: body mass index, NR: not reported.

aEpidural analgesia vs. nerve block.
Korean J Pain 2021;34:271~287 https://doi.org/10.3344/kjp.2021.34.3.271
© Korean J Pain
© The Korean Pain Society. / Powered by INFOrang Co., Ltd